Abstract
Hepatitis B and hepatitis C virus (HBV and HCV, respectively) infections are major causes of acute and chronic liver diseases that cause an estimated 1.4 million deaths globally each year. Antiviral treatments can prevent the majority of deaths related to these diseases. However, access to testing and treatment is limited, especially in lower and medium income countries (LMIC) due the hig…